SciELO - Scientific Electronic Library Online

 
vol.19 issue5Factors that predict unplanned hospital readmission of patients discharged from a Short Stay Medical UnitProgressive Multifocal Leukoencephalopathy in AIDS patients: any change in the highly active antiretrovial therapies era? author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

Share


Anales de Medicina Interna

Print version ISSN 0212-7199

Abstract

CALVO ROMERO, J. Mª. et al. Primary antiphospholipid syndrome: characteristics and evolution of a series of 17 cases. An. Med. Interna (Madrid) [online]. 2002, vol.19, n.5, pp.14-19. ISSN 0212-7199.

Background: Primary antiphospholipid syndrome (APS) is a thrombophilic disorder which is not associated with connective tissue diseases or with other diseases.  Method: Retrospective review of patients diagnosed of primary APS in an Internal Medicine service between January 1996 and December 2000.  Results: We identified 17 patients with primary APS. The most common presenting manifestations were deep vein thrombosis (7 cases) and ischemic stroke (3 cases). Eleven patients (65%) had vein thrombosis, 4 (24%) arterial thrombosis and no patient had both types of thrombosis. The 15 patients with thrombosis received treatment with indefinite oral anticoagulation (INR between 2.5 and 3.5). There was no recurrence of thrombosis or major hemorrhagic complications after a median follow-up time of 36 months (range 10-52 months).  Conclusions: The most common presenting manifestation of primary APS is deep vein thrombosis. Venous thrombosis is more frequent than arterial thrombosis. The occurrence of both types of thrombosis seems to be exceptional. Long-term oral anticoagulation is an effective and safe treatment to prevent the recurrence of thrombosis in patients with primary APS.

Keywords : Antiphospholipid syndrome; Thrombosis; Oral anticoagulation.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License